Republican Congressional Leaders Decline to Recommend Appointments to the Medicare Independent Payment Advisory Board

In a letter to President Obama, House Speaker Boehner (R-OH) and Senate Republican Leader Mitch McConnell (R-KY) announced that they are declining to recommend Republican appointments to the Independent Payment Advisory Board (IPAB). The board, established by section 3403 of the Patient Protection and Affordable Care Act (PPACA) (P.L. 111-148) and codified in section 1899A of the Social Security Act, is designed to reduce the per capita rate of growth of Medicare spending. When certain conditions are met the IPAB members will meet and develop recommendations for Congress to reduce Medicare spending. The board is limited in how it can reduce spending. The members of the IPAB are to be appointed by the President and confirmed by the Senate. To date no one has been appointed to the board.

Membership is to be composed of 15 individuals and include physicians and health care professionals from various health care professions and regions of the country. On March 29, 2013, President Obama requested recommendations for IPAB membership from Speaker Boehner and Leader McConnell. In their joint response, they stated that “because the law will give IPAB’s 15 unelected, unaccountable individuals the ability to deny seniors access to innovative care, we respectfully decline to recommend appointments.”

The letter went on to state that the leaders hope that establishing the IPAB never becomes a reality as a full repeal of PPACA remains the goal of both leaders. According to the letter Speaker Boehner and Leader McConnell believe that they should “work in a bipartisan manner to develop the long-term structural changes that are needed to strengthen and protect Medicare for today’s seniors, their children and their grandchildren.” It is anticipated that the House will again set up to vote on repealing PPACA in the near future.

Kusserow’s Corner

We are pleased to unveil a new addition to the Wolters Kluwer Law & Business health blog- Kusserow’s Corner. Here you can find all of the content provided to us by our outside contributor Richard P. Kusserow. Richard was the Department of Health and Human Services Inspector General for over eleven years.  He is the author of nine books related to compliance.  He is the founder and CEO of Strategic Management, a firm that has been providing specialized compliance advisory services since 1992 to 2,000 clients. Richard now contributes content to  Wolters Kluwer to assist the industry in their understanding of compliance from the perspective of a former Inspector General.

HealthBlog_KusserowsCorner.Draft2

We look forward to learning from Richard’s perspective!

Testing of “Organ in a Box” Yields Promising Results

Although it might seem like science fiction, scientists have created a box  to keep transplant organs “alive” during their transport. The Organ Care System™ (OCS) maintains the organ in a functioning state during shipment.  The company making them hopes to submit the device to the Food and Drug Administration for approval in the future.

According to CNN, the OCS LUNG is approved in Europe and is undergoing clinical trials in the United States. Preliminary results showed that patients whose donated lung was transported in the box had fewer complications and greater overall outcome. TransMedics, the company behind the OCS, hopes to start a new era in organ transplants. According to their website:

Lung transplantation programs around the world face significant challenges in organ availability, patient outcomes, and overall cost of patient care caused by the limitations of the current cold static lung preservation method.

The OCS™ LUNG is a portable perfusion, ventilation, and monitoring system that maintains the organ in a near physiologic state. The system enables surgeons to perfuse and ventilate the organ between the donor and recipient sites.

Image Courtesy of TransMedic.com

Image Courtesy of TransMedic.com

TransMedics is currently testing out a similar device for donor heart transportation. CNN reports that the device costs approximately $58,000, and the internal chamber must be replaced for each patient.